D. Averill

2.8k total citations
7 papers, 604 citations indexed

About

D. Averill is a scholar working on Genetics, Public Health, Environmental and Occupational Health and Economics and Econometrics. According to data from OpenAlex, D. Averill has authored 7 papers receiving a total of 604 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 3 papers in Public Health, Environmental and Occupational Health and 2 papers in Economics and Econometrics. Recurrent topics in D. Averill's work include BRCA gene mutations in cancer (4 papers), Ethics in Clinical Research (2 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). D. Averill is often cited by papers focused on BRCA gene mutations in cancer (4 papers), Ethics in Clinical Research (2 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). D. Averill collaborates with scholars based in United Kingdom, Ireland and United States. D. Averill's co-authors include Douglas F. Easton, Michael R. Stratton, Richard Wooster, Rosalind A. Eeles, W. Ormiston, Deborah Ford, David E. Goldgar, Ross McManus, Peter A. Daly and Linda Steele and has published in prestigious journals such as Nature Genetics, The American Journal of Human Genetics and Psycho-Oncology.

In The Last Decade

D. Averill

7 papers receiving 578 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Averill United Kingdom 6 434 243 163 147 131 7 604
W. Ormiston Ireland 7 501 1.2× 248 1.0× 119 0.7× 127 0.9× 138 1.1× 10 629
B. A. J. Ponder United Kingdom 10 594 1.4× 275 1.1× 134 0.8× 196 1.3× 171 1.3× 15 822
Gemma Llort Spain 14 435 1.0× 314 1.3× 149 0.9× 144 1.0× 161 1.2× 32 638
JudyE. Garber United States 5 329 0.8× 282 1.2× 327 2.0× 353 2.4× 252 1.9× 5 787
Helen Byers United Kingdom 14 429 1.0× 183 0.8× 217 1.3× 71 0.5× 144 1.1× 30 651
Jacqueline Mersch United States 3 333 0.8× 185 0.8× 173 1.1× 123 0.8× 148 1.1× 9 544
Anu Chittenden United States 12 328 0.8× 120 0.5× 174 1.1× 231 1.6× 212 1.6× 32 599
Lise Sveen United States 9 450 1.0× 389 1.6× 247 1.5× 61 0.4× 211 1.6× 18 738
Kristiina Aittomäki Finland 7 162 0.4× 171 0.7× 136 0.8× 117 0.8× 84 0.6× 8 471
Izabela Brożek Poland 15 429 1.0× 353 1.5× 97 0.6× 95 0.6× 108 0.8× 23 583

Countries citing papers authored by D. Averill

Since Specialization
Citations

This map shows the geographic impact of D. Averill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Averill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Averill more than expected).

Fields of papers citing papers by D. Averill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Averill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Averill. The network helps show where D. Averill may publish in the future.

Co-authorship network of co-authors of D. Averill

This figure shows the co-authorship network connecting the top 25 collaborators of D. Averill. A scholar is included among the top collaborators of D. Averill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Averill. D. Averill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Easton, Douglas F., Linda Steele, W. Ormiston, et al.. (1997). Cancer Risks in Two Large Breast Cancer Families Linked to BRCA2 on Chromosome 13q12‐13. The American Journal of Human Genetics. 61(1). 120–128. 278 indexed citations
2.
Watson, Maggie, Samuel Lloyd, Rosalind A. Eeles, et al.. (1996). Psychosocial impact of testing (by linkage) for the BRCA1 breast cancer gene: An investigation of two families in the research setting. Psycho-Oncology. 5(3). 233–239. 36 indexed citations
3.
Watson, Maggie, Samuel Lloyd, Rosalind A. Eeles, et al.. (1996). Psychosocial impact of testing (by linkage) for the BRCA1 breast cancer gene: An investigation of two families in the research setting. Psycho-Oncology. 5(3). 233–239. 1 indexed citations
4.
Eeles, Rosalind A., et al.. (1993). Constitutional mutation in exon 8 of the p53 gene in a patient with multiple primary tumours: molecular and immunohistochemical findings.. PubMed. 8(5). 1269–76. 46 indexed citations
5.
Smith, Simon A., Douglas F. Easton, Deborah Ford, et al.. (1993). Genetic heterogeneity and localization of a familial breast-ovarian cancer gene on chromosome 17q12-q21.. PubMed. 52(4). 767–76. 39 indexed citations
6.
Wooster, Richard, Jonathan Mangion, Rosalind A. Eeles, et al.. (1992). A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome. Nature Genetics. 2(2). 132–134. 165 indexed citations
7.
Warren, William, Rosalind A. Eeles, D. Averill, et al.. (1992). No evidence for germline mutations in exons 5-9 of the p53 gene in 25 breast cancer families.. PubMed. 7(5). 1043–6. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026